ID NB69 AC CVCL_1448 SY NB-69; NB_69; NB 69; NB69-RIKEN DR BTO; BTO_0005426 DR CLO; CLO_0050263 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-3610 DR BioGRID_ORCS_Cell_line; 951 DR BioSample; SAMN03470996 DR cancercelllines; CVCL_1448 DR Cell_Model_Passport; SIDM00244 DR ChEMBL-Cells; CHEMBL3308799 DR ChEMBL-Targets; CHEMBL1075510 DR Cosmic; 688081 DR Cosmic; 801739 DR Cosmic; 908440 DR Cosmic; 920248 DR Cosmic; 930069 DR Cosmic; 947709 DR Cosmic; 1019930 DR Cosmic; 1037342 DR Cosmic; 1099139 DR Cosmic; 1109123 DR Cosmic; 1153787 DR Cosmic; 1890119 DR Cosmic; 2058110 DR Cosmic; 2131577 DR Cosmic-CLP; 908440 DR DepMap; ACH-002083 DR ECACC; 99072802 DR EGA; EGAS00001000978 DR GDSC; 908440 DR GEO; GSM313807 DR GEO; GSM563353 DR GEO; GSM827391 DR GEO; GSM1670154 DR GEO; GSM2371245 DR GEO; GSM2394385 DR GEO; GSM3145588 DR GEO; GSM3145725 DR GEO; GSM4104585 DR GEO; GSM4104586 DR GEO; GSM4104632 DR GEO; GSM4104633 DR GEO; GSM4104634 DR GEO; GSM4105323 DR GEO; GSM4105324 DR GEO; GSM4105325 DR GEO; GSM4105326 DR GEO; GSM4105327 DR IARC_TP53; 21531 DR IARC_TP53; 27184 DR LINCS_LDP; LCL-1999 DR PharmacoDB; NB69_993_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_1448 DR PubChem_Cell_line; CVCL_1448 DR RCB; RCB0480 DR Wikidata; Q54907543 RX DOI=10.1007/0-306-46872-7_2; RX DOI=10.1016/B978-0-12-333530-2.50006-X; RX PubMed=16822308; RX PubMed=18923524; RX PubMed=20164919; RX PubMed=20215515; RX PubMed=23202128; RX PubMed=25877200; RX PubMed=27397505; RX PubMed=28350380; RX PubMed=30894373; RX PubMed=30971826; RX PubMed=35839778; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Caucasian. CC Microsatellite instability: Stable (MSS) (Sanger). CC Omics: Genomics; ChIP-seq; H3K27ac. CC Omics: Genomics; ChIP-seq; H3K27me3. CC Omics: Genomics; ChIP-seq; H3K4me1. CC Omics: Genomics; ChIP-seq; H3K4me3. CC Omics: Genomics; Chromatin accessibility; ATAC-seq. CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; CRISPR screening. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0.26%; East Asian, North=0.67%; East Asian, South=0%; South Asian=0.54%; European, North=64.54%; European, South=34% (PubMed=30894373). ST Source(s): Cosmic-CLP=908440; ECACC=99072802; PubMed=25877200; RCB=RCB0480 ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D13S317: 8 ST D16S539: 9,11 ST D18S51: 15,16 ST D19S433: 14,15 ST D21S11: 30.2,31.2,32 ST D2S1338: 17,23 ST D3S1358: 16,17 ST D5S818: 11,12 ST D7S820: 10 ST D8S1179: 13.2,14,15 ST FGA: 21,25 ST Penta D: 7,12 ST Penta E: 10,13 ST TH01: 8 ST TPOX: 8,11 (Cosmic-CLP=908440; PubMed=25877200; RCB=RCB0480) ST TPOX: 11 (ECACC=99072802) ST vWA: 17,18 DI NCIt; C3270; Neuroblastoma DI ORDO; Orphanet_635; Neuroblastoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 1Y4M CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 45 // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=28350380; DOI=10.1038/sdata.2017.33; PMCID=PMC5369315; RA Harenza, Jo Lynne RA Diamond, Maura A. RA Adams, Rebecca N. RA Song, Michael M. RA Davidson, Heather L. RA Hart, Lori S. RA Dent, Maiah H. RA Fortina, Paolo RA Reynolds, Charles Patrick RA Maris, John Matthew RT "Transcriptomic profiling of 39 commonly-used neuroblastoma cell RT lines."; RL Sci. Data 4:170033.1-170033.8(2017). // RX PubMed=18923524; DOI=10.1038/nature07399; RA Chen, Yu-Yan RA Takita, Junko RA Choi, Young Lim RA Kato, Motohiro RA Ohira, Miki RA Sanada, Masashi RA Wang, Li-Li RA Soda, Manabu RA Kikuchi, Akira RA Igarashi, Takashi RA Nakagawara, Akira RA Hayashi, Yasuhide RA Mano, Hiroyuki RA Ogawa, Seishi RT "Oncogenic mutations of ALK kinase in neuroblastoma."; RL Nature 455:971-974(2008). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX DOI=10.1016/B978-0-12-333530-2.50006-X; RA Israel, Mark A. RA Thiele, Carol Jeanne RT "Tumor cell lines of the peripheral nervous system."; RL (In book chapter) Atlas of human tumor cell lines; Hay, Robert J. & Park, Jae-Gahb & Gazdar, Adi F. (eds.); pp.43-78; Academic Press; New York; USA (1994). // RX DOI=10.1007/0-306-46872-7_2; RA Thiele, Carol Jeanne RT "Neuroblastoma."; RL (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=16822308; DOI=10.1186/1471-2407-6-177; PMCID=PMC1533846; RA Dam, Vincent RA Morgan, Brian T. RA Mazanek, Pavel RA Hogarty, Michael D. RT "Mutations in PIK3CA are infrequent in neuroblastoma."; RL BMC Cancer 6:177.1-177.10(2006). // RX PubMed=23202128; DOI=10.1038/ng.2493; PMCID=PMC3557959; RA Sausen, Mark RA Leary, Rebecca J. RA Jones, Sian RA Wu, Jian RA Reynolds, Charles Patrick RA Liu, Xue-Yuan RA Blackford, Amanda L. RA Parmigiani, Giovanni RA Diaz, Luis Alberto Jr. RA Papadopoulos, Nickolas RA Vogelstein, Bert RA Kinzler, Kenneth Wayne RA Velculescu, Victor E. RA Hogarty, Michael D. RT "Integrated genomic analyses identify ARID1A and ARID1B alterations in RT the childhood cancer neuroblastoma."; RL Nat. Genet. 45:12-17(2013). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=30971826; DOI=10.1038/s41586-019-1103-9; RA Behan, Fiona M. RA Iorio, Francesco RA Picco, Gabriele RA Goncalves, Emanuel RA Beaver, Charlotte M. RA Migliardi, Giorgia RA Santos, Rita RA Rao, Yanhua RA Sassi, Francesco RA Pinnelli, Marika RA Ansari, Rizwan RA Harper, Sarah RA Jackson, David Adam RA McRae, Rebecca RA Pooley, Rachel RA Wilkinson, Piers RA van der Meer, Dieudonne J. RA Dow, David RA Buser-Doepner, Carolyn A. RA Bertotti, Andrea RA Trusolino, Livio RA Stronach, Euan Alexander RA Saez-Rodriguez, Julio RA Yusa, Kosuke RA Garnett, Mathew J. RT "Prioritization of cancer therapeutic targets using CRISPR-Cas9 RT screens."; RL Nature 568:511-516(2019). //